Published in Lancet on June 16, 2007
Alternative tobacco product use and smoking cessation: a national study. Am J Public Health (2013) 3.18
Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health (2010) 2.94
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol (2009) 2.90
Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med (2007) 2.10
Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA. Tob Control (2010) 2.04
Receptivity to Taboka and Camel Snus in a U.S. test market. Nicotine Tob Res (2009) 1.79
Non-cigarette tobacco products: what have we learnt and where are we headed? Tob Control (2012) 1.58
The scientific foundation for tobacco harm reduction, 2006-2011. Harm Reduct J (2011) 1.57
Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med (2009) 1.52
Prevalence of trial of snus products among adult smokers. Am J Public Health (2011) 1.50
Is low-nicotine Marlboro snus really snus? Harm Reduct J (2008) 1.40
Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education. Glob Health Action (2011) 1.29
Should doctors advocate snus and other nicotine replacements? Yes. BMJ (2008) 1.22
Tobacco use harm reduction, elimination, and escalation in a large military cohort. Am J Public Health (2010) 1.22
Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking? Int J Environ Res Public Health (2008) 1.18
Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch. Nicotine Tob Res (2011) 1.12
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Snus--what should the public-health response be? Lancet (2007) 1.09
The STAGE cohort: a prospective study of tobacco use among Swedish twins. Nicotine Tob Res (2008) 1.02
Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med (2015) 1.01
Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord (2009) 1.01
Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States. Am J Public Health (2009) 1.00
Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer (2008) 0.98
Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduct J (2013) 0.97
Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch. Nicotine Tob Res (2014) 0.96
Public education about the relative harm of tobacco products: an intervention for tobacco control professionals. Tob Control (2013) 0.96
Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer (2012) 0.95
Snus use and other correlates of smoking cessation in the Swedish Twin Registry. Psychol Med (2008) 0.95
The European Parliament proposal for the new EU General Data Protection Regulation may severely restrict European epidemiological research. Eur J Epidemiol (2014) 0.94
Risk factors and therapeutic targets in pancreatic cancer. Front Oncol (2013) 0.88
Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev (2012) 0.87
Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Br J Cancer (2013) 0.85
The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews. BMC Cancer (2009) 0.84
Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus. Nicotine Tob Res (2012) 0.84
Impact of smokeless tobacco packaging on perceptions and beliefs among youth, young adults, and adults in the U.S: findings from an internet-based cross-sectional survey. Harm Reduct J (2014) 0.84
Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol (2010) 0.83
The association between smokeless tobacco use and pancreatic adenocarcinoma: a systematic review. Cancer Epidemiol (2014) 0.82
High levels of tobacco-specific N-nitrosamines and nicotine in Chaini Khaini, a product marketed as snus. Tob Control (2014) 0.81
Drug addiction is associated with leukocyte telomere length. Sci Rep (2013) 0.80
Snus and the risk of cancer of the mouth, lung, and pancreas. Lancet (2007) 0.79
Should doctors advocate snus and other nicotine replacements? No. BMJ (2008) 0.79
Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers. Tob Control (2016) 0.79
Use of snus, its association with smoking and alcohol consumption, and related attitudes among adolescents: the Finnish National School Health Promotion Study. Tob Induc Dis (2015) 0.78
Non-Smoking Tobacco Affects Endothelial Function in Healthy Men in One of the Largest Health Studies Ever Performed; The Nord-Trøndelag Health Study in Norway; HUNT3. PLoS One (2016) 0.77
Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece. Int J Environ Res Public Health (2016) 0.76
Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness. Harm Reduct J (2009) 0.76
Prevalence and factors that influence smokeless tobacco use among adults in pastoralist communities of Borena Zone, Ethiopia: mixed method study. Tob Induc Dis (2017) 0.75
Evaluation of Oral Changes Among Tobacco Users of Aljouf Province, Saudi Arabia. J Clin Diagn Res (2015) 0.75
Attentional bias in snus users: an experimental study. PLoS One (2014) 0.75
Smoking cessation: it is never too late. Diabetes Care (2009) 0.75
Putting tobacco harm reduction in perspective: is it a viable alternative? Indian J Med Res (2016) 0.75
The effect of Swedish snuff (snus) on offspring birthweight: a sibling analysis. PLoS One (2013) 0.75
The tobacco-using periodontal patient: role of the dental practitioner in tobacco cessation and periodontal disease management. Periodontol 2000 (2016) 0.75
Effect of the use of snuff on the levels of interleukin-1 β and interleukin-8 in the gingival crevicular fluid of periodontitis patients. Dent Res J (Isfahan) (2015) 0.75
Midwakh/dokha tobacco use in the Middle East: much to learn. Tob Control (2014) 0.75
Tobacco use and cancer risk in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products. Toxicol Lett (2016) 0.75
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2005) 16.35
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med (2002) 10.64
Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06
Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst (2008) 8.62
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78
Natural history of early, localized prostate cancer. JAMA (2004) 7.44
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50
Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ (2012) 4.05
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet (2009) 4.01
Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ (2004) 3.67
Obesity and risk for chronic renal failure. J Am Soc Nephrol (2006) 3.67
Listing occupational carcinogens. Environ Health Perspect (2004) 3.57
Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56
Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol (2008) 3.56
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ (2005) 3.48
Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol (2011) 3.45
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst (2003) 3.29
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst (2005) 3.19
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84
Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res (2009) 2.77
Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77
Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer (2005) 2.73
Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet (2002) 2.72
Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71
Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol (2007) 2.64
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62
Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology (2007) 2.60
Average energy intake among pregnant women carrying a boy compared with a girl. BMJ (2003) 2.55
Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol (2005) 2.54
Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet (2008) 2.53
Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma. Eur J Cancer Prev (2012) 2.51
Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49
Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 2.47
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40
Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr (2004) 2.39
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol (2014) 2.35
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr (2008) 2.35
Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol (2012) 2.28
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res (2005) 2.24
Genetics of lung-cancer susceptibility. Lancet Oncol (2010) 2.24
Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study. Lancet (2011) 2.24
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst (2006) 2.23
The socioeconomic gradient in the incidence of stroke: a prospective study in middle-aged women in Sweden. Stroke (2006) 2.23
Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19
Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies. Cancer Causes Control (2012) 2.18
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18
Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis. Dig Liver Dis (2012) 2.15
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology (2008) 2.11
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07
Russian mortality trends for 1991-2001: analysis by cause and region. BMJ (2003) 2.05
Comparison of two statistical approaches to predict all-cause mortality by dietary patterns in German elderly subjects. Br J Nutr (2005) 2.04
Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst (2005) 2.03
Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer (2003) 2.03
Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol (2007) 2.02
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01